The stimulants revisited

Child and Adolescent Psychiatric Clinics of North America

Volumn 9, Issue 3, 2000, Pages 573-603

  Wilens, T E ^a   Spencer, T J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; CLONIDINE; DEXAMPHETAMINE; METHAMPHETAMINE; METHYLPHENIDATE; MIRTAZAPINE; NORTRIPTYLINE; PEMOLINE MAGNESIUM; PERGOLIDE; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER; BODY WEIGHT DISORDER; CHILD; COMORBIDITY; DRUG ABSORPTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG USE; GROWTH RETARDATION; HUMAN; HYPERACTIVITY; INSOMNIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 0033853996     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1056-4993(18)30108-1     Document Type: Review

References (179)

1. Abikoff H. Gittelman R. The normalizing effects of methylphenidate on the classroom behavior of ADHD children J Abnorm Child Psychol 13 1985 33=-N44
2. Abikoff H. Hechtman L. Advanced topics in psychopharmacology: Multimodal treatment Scientific Proceedings of the American Academy of Child and Adolescent Psychiatry 1995 American Academy of Child and Adolescent Psychiatry New Orleans
3. Alles G.A. The comparative physiological action of phenylethanolamine J Pharmacol Exp Ther 32 1928 121 128
4. Aman M. Recent studies in psychopharmacology in mental retardation Bray N. International Review of Research in Mental Retardation 1997 Academic Press New York 113 146
5. Aman M. Kern R. Osborne P. Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: Clinical effects Am J Ment Retard 101 1997 521 534
6. Aman M.G. Marks R.E. Turbott S.H. Clinical effects of methylphenidate and thioridazine in intellectually subaverage children J Am Acad Child Adolesc Psychiatry 30 1991 246 256
7. Angrist B. Corwin J. Bartlik B. Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects Biol Psychiatry 22 1987 1357 1368
8. Anngard E. Gunne L.M. Jonsson L. Pharmacokinetic and clinical studies on amphetamine dependent subjects Eur J Clin Pharmacol 3 1970 3 11
9. Barkley R.A. A review of stimulant drug research with hyperactive children J Child Psychol Psychiatry 18 1977 137 165
10. Barkley R.A. The effects of methylphenidate on the interactions of preschool ADHD children with their mothers J Am Acad Child Adolesc Psychiatry 27 1988 336 341
11. Barkley R.A. Hyperactive girls and boys: Stimulant drug effects on mother-child interactions J Child Psychol Psychiatry 30 1989 379 390
12. Barkley R.A. Cunningham C.E. The effects of methylphenidate on the mother-child interactions of hyperactive children Arch Gen Psychiatry 36 1979 201 208
13. Barkley R.A. Karlsson J. Strzelecki E. Effects of age and ritalin dosage on mother- child interactions of hyperactive children J Consult Clin Psychol 52 1984 750 758
14. Barkley R.A. McMurray M.B. Edelbrock C.S. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation Pediatrics 86 1990 184 192
15. Beck L. Langford W. Mackay M. Childhood chemotherapy and later drug abuse and growth curve: A follow-up study of 30 adolescents Am J Psychiatry 132 1975 436 438
16. Biederman J. Faraone S. Milberger S. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders Arch Gen Psychiatry 53 1996 437 446
17. Biederman J. Mick E. Bostic J. The naturalistic course of pharmacologic treatment of children with maniclike symptoms: A systematic chart review J Clin Psychiatry 59 1998 628 637
18. Biederman J. Mick E. Bostic J.Q. Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder J Child Adolescent Psychopharmacol 9 1999 247 256
19. Biederman J. Newcom J. Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders Am J Psychiatry 148 1991 564 577
20. Biederman J. Wilens T. Mick E. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder Pediatrics 104 1999 E20
21. Biel J.M. Structure-activity relationships of amphetamine and derivatives Costa F. Garattini S. Amphetamines and Related Compounds 1970 Raven Press New York 3 19
22. Birmaher B. Greenhill L.L. Cooper T.B. Sustained release methylphenidate: Pharmacokinetic studies in ADDH males J Am Acad Child Adolesc Psychiatry 28 1989 768 772
23. Birmaher B. Quintana H. Greenhill L.L. Methylphenidate treatment of hyperactive autistic children J Am Acad Child Adolesc Psychiatry 27 1988 248 251
24. Bloom A.S. Russell L.J. Weisskopf B. Methylphenidate-induced delusional disorder in a child with attention deficit disorder with hyperactivity J Am Acad Child Adolesc Psychiatry 27 1988 88 89
25. Borcherding B.G. Keysor C.S. Rapoport J.L. Motor/vocal tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability? Psychiatry Res 33 1990 83 94
26. Bostic J, Biederman J, Spencer T, et al: Pemoline treatment of adolescents with attention-deficit/hyperactivity disorder: A ten-week controlled trial. J Child Adolesc Psychopharmacol, in press
27. Bradley C. The behavior of children receiving benzedrine Am J Psychiatry 94 1937 577 585
28. Brown R.T. Sexson S.B. A controlled trial of methylphenidate in black adolescents Clin Pediatr 27 1988 74 81
29. Brown R.T. Wynne M.E. Slimmer L.W. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning J Clin Psychiatry 45 1984 473 476
30. Caldwell J. Sever P.S. The biochemical pharmacology of abused drugs Clin Pharmacol Ther 16 1974 625 638
31. Castellanos F.X. Giedd J.N. Elia J. Controlled stimulant treatment of ADHD and comorbid Tourette’s syndrome: Effects of stimulant and dose J Am Acad Child Adolesc Psychiatry 36 1997 1 8
32. Collier C.P. Soldin S.J. Swanson J.M. Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity Clin Pharmacokinet 10 1985 269 278
33. Conners C.K. Controlled trial of methylphenidate in preschool children with minimal brain dysfunction Gittelman-Klein R. Recent Advances in Child Psychopharmacology 1975 Human Sciences Press New York 65 78
34. Coons H.W. Klorman R. Borgstedt A.D. Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: II. Information processing J Am Acad Child Adolesc Psychiatry 26 1987 368 374
35. Cunningham C. Siegel L. Offord D. A developmental dose-response analysis of the effects of methylphenidate on the peer interactions of attention deficit disordered boys J Child Psychol Psychiatry 26 1985 955 971
36. DEA: Methylphenidate Review Document Drug Enforcement Administration: Office of Diversion Control, Drug and Chemical Evaluation Section 1995 Drug Enforcement Administration Washington, DC
37. Denckla M.B. Bemporad J.R. MacKay M.C. Tics following methylphenidate administration: A report of 20 cases JAMA 235 1976 1349 1351
38. DeVane C.L. Pharmacokinetics of the selective serotonin reuptake inhibitors J Clin Psychiatry 53 1992 13 20
39. Diamond I. Tannock R. Schachar R. Response to methylphenidate in children with ADHD and comorbid anxiety J Am Acad Child Adolesc Psychiatry 38 1999 402 409
40. Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 36 1997 85 121 (suppl)
41. Dulcan M.K. Using psychostimulants to treat behavioral disorders of children and adolescents J Child Adolesc Psychopharmacol 1 1990 7 20
42. DuPaul G. The ADHD rating scale: Normative data, reliability, and validity Unpublished manuscript of the University of Massachusetts Medical School 1990
43. DuPaul G.J. Barkley R.A. McMurray M.B. Response of children with ADHD to methylphenidate: Interaction with internalizing symptoms J Am Acad Child Adolesc Psychiatry 33 1994 894 903
44. Elia J. Stimulants and antidepressant pharmacokinetics in hyperactive children Psychopharmacol Bull 27 1991 411 415
45. Elia J. Borcherding B.G. Potter W.Z. Stimulant drug treatment of hyperactivity: Biochemical correlates Clin Pharmacol Ther 48 1990 57 66
46. Elia J. Borcherding B.G. Rapoport J.L. Methylphenidate and dextroamphetamine treatments of hyperactivity: Are there true nonresponders? Psychiatry Res 36 1991 141 155
47. Famularo R. Fenton T. The effect of methylphenidate on school grades in children with attention deficit disorder without hyperactivity: A preliminary study J Clin Psychiatry 48 1987 112 114
48. Faraone S.V. Biederman J. Keenan K. Separation of DSM III attention deficit disorder and conduct disorder: Evidence from a family genetic study of American child psychiatric patients Psychol Med 21 1991 109 121
49. Fawcett J. Busch K.A. Stimulants in Psychiatry Schatzberg A. Nemeroff C. Textbook of Psychopharmacology 1995 American Psychiatric Association Washington, DC 417 435
50. Feldman H. Crumrine P. Handen B.L. Methylphenidate in children with seizures and attention-deficit disorder Am J Dis Child 143 1989 1081 1086
51. Findling R.L. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: A case series J Child Adolesc Psychopharmacol 6 1996 165 175
52. Gadow K. Sverd J. Sprafkin J. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder Arch Gen Psychiatry 56 1999 330 336
53. Gadow K.D. Effects of stimulant drugs on academic performance in hyperactive and learning disabled children J Learn Disabil 16 1983 290 299
54. Gadow K.D. Prevalence of drug treatment for hyperactivity and other childhood behavior disorders Gadow K.D. Loney J. Psychosocial Aspects of Drug Treatment for Hyperactivity 1981 Westview Press Boulder 13 76
55. Gadow K.D. Nolan E.E. Sverd J. Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings J Am Acad Child Adolesc Psychiatry 31 1992 462 471
56. Gadow K.D. Nolan E.E. Sverd J. Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings J Am Acad Child Adolesc Psychiatry 29 1990 710 718
57. Gadow K.D. Sverd J. Sprafkin J. Efficacy of methylphenidate for attention- deficit hyperactivity disorder in children with tic disorder Arch Gen Psychiatry 52 1995 444 455
58. Gammon G.D. Brown T.E. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder J Child Adolesc Psychopharmacol 3 1993 1 10
59. Geller B. Sun K. Zimerman B. Complex and rapid-cycling in bipolar children and adolescents: A preliminary study J Affect Disord 38 1995 1 10
60. Gillberg C. Melander H. Knorring A. Long-term stimulant treatment of children with ADHD symptoms: A randomized, double-blind, placebo-controlled trial Arch Gen Psychiatry 54 1997 865 870
61. Gittelman R. Mannuzza S. Hyperactive boys almost grown up: III. Methylphenidate effects on ultimate height Arch Gen Psychiatry 45 1988 1131 1134
62. Glennon R.A. Psychoactive phenylisopropylamines Meltzer H.Y. Psychopharmacology: The Third Generation of Progress 1987 Raven Press New York 1627 1634
63. Goff D.C. Ciraulo D.A. Stimulants Ciraulo D.A. Shader R.I. Clinical Manual of Chemical Dependence 1991 American Psychiatric Press Washington, DC 233 257
64. Grabowski J. Roache J.D. Schmitz J.M. Replacement medication for cocaine dependence: Methylphenidate J Clin Psychopharmacol 17 1997 485 488
65. Greenhill L. Osman B. Ritalin: Theory and Practice 1999 Mary Ann Liebert New York
66. Gross M. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine Pediatrics 58 1976 423 431
67. Gross-Tsur V. Manor O. Meere J. Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective? J Pediatr 130 1997 40 44
68. Gualtieri C.T. Hicks R.E. Neuropharmacology of methylphenidate and a neural substrate for childhood hyperactivity Psychiatr Clin North Am 8 1985 875 892
69. Gualtieri C.T. Ondrusek M.G. Finley C. Attention deficit disorder in adults Clin Neuropharmacol 8 1985 343 356
70. Hagerman R.J. Murphy M.A. Wittenberg M.D. A controlled trial of stimulant medication in children with the fragile X syndrome Am J Med Genet 30 1988 377 392
71. Handen B.L. Feldman H. Gosling A. Adverse side effects of methylphenidate among mentally retarded children with ADHD J Am Acad Child Adolesc Psychiatry 30 1991 241 245
72. Handen B.L. Janosky J. McAuliffe S. Prediction of response to methylphenidate among children with ADHD and mental retardation J Am Acad Child Adolesc Psychiatry 33 1994 1185 1193
73. Hechtman L. Adolescent outcome of hyperactive children treated with stimulants in childhood: A review Psychopharmacol Bull 21 1985 178 191
74. Hinshaw S. Heller T. McHale J. Covert antisocial behavior in boys with attention- deficit hyperactivity disorder: External validation and effects of methylphenidate J Consult Clin Psychol 60 1992 274 281
75. Hinshaw S. Lee S. Ritalin effects on aggression and antisocial behavior Greenhill L. Osman B. Ritalin: Theory and Practice 1999 Mary Ann Liebert New York 237 264
76. Hinshaw S.P. Buhrmester D. Heller T. Anger control in response to verbal provocation: Effects of stimulant medication for boys with ADHD J Abnorm Child Psychol 17 1989 393 407
77. Hoffman B.B. Lefkowitz R.J. Catecholamines and sympathomimetic drugs Gilman A.G. Rall T.W. Nies A.S. The Pharmacological Basis of Therapeutics 1990 Pergamon Press New York 187 220
78. Hubbard J.W. Srinivas N.R. Quinn D. Enantioselective aspects of the disposition of dl-threo-methylphenidate after the administration of a sustained-release formulation to children with attention deficit disorder J Pharmacol Sci 78 1989 944 947
79. Iaboni F. Bouffard R. Minde K. The efficacy of methylphenidate in treating adults with attention-deficit/hyperactivity disorder Scientific Proceedings of the American Academy of Child and Adolescent Psychiatry 1996 American Academy of Child and Adolescent Psychiatry Philadelphia
80. Jaffe S.L. Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD J Am Acad Child Adolesc Psychiatry 30 1991 773 775
81. Jensen P. Multimodal treatment of ADHD: Findings from the NIMH collaborative study Scientific Proceedings of the American Academy of Child and Adolescent Psychiatry 1998 American Academy of Child and Adolescent Psychiatry Anaheim
82. Jensen P. Kettle L. Roper M. Are stimulants overperscribed? Treatment of ADHD in four U.S. communities J Am Acad Child Adolesc Psychiatry 38 1999 797 804
83. Johnston C. Pelham W.E. Hoza J. Psychostimulant rebound in attention deficit disordered boys J Am Acad Child Adolesc Psychiatry 27 1988 806 810
84. Kelly K.L. Rapport M.D. DuPaul G.J. Attention deficit disorder and methylphenidate: A multi-step analysis of dose-response effects on childrens cardiovascular functioning Int Clin Psychopharmacol 3 1988 167 181
85. Klein R. Mannuzza S. Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height Arch Gen Psychiatry 45 1988 1131 1134
86. Klein R.G. Pharmacotherapy of childhood hyperactivity: An update Meltzer H.Y. Psychopharmacology: The Third Generation of Progress 1987 Raven Press New York 1215 1225
87. Klein R.G. Abikoff H. Klass E. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder Arch Gen Psychiatry 54 1997 1073 1080
88. Klein R.G. Bessler A.W. Stimulant side effects in children Kane J.M. Lieberman J.A. Adverse Effects of Psychotropic Drugs 1992 Guilford Press New York 470 496
89. Klorman R. Coons H.W. Borgstedt A.D. Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder I: Clinical findings J Am Acad Child Adolesc Psychiatry 26 1987 363 367
90. Koehler-Troy C. Strober M. Malenbaum R. Methylphenidate induced mania in a prepubertal child J Clin Psychiatry 47 1986 566 567
91. Konkol R. Fischer M. Newby R. Double-blind, placebo-controlled stimulant trial in children with Tourette’s syndrome and ADHD: Abstract Ann Neurol 28 1990 424
92. Kramer J. Loney J. Whaley-Klahn M. The role of prescribed medication in hyperactive youths’ substance use Scientific Proceedings of the American Psychological Association 1981 Los Angeles American Psychological Association
93. Kupietz S.S. Winsberg B.G. Richardson E. Effects of methylphenidate dosage in hyperactive reading-disabled children: I. Behavior and cognitive performance effects J Am Acad Child Adolesc Psychiatry 27 1988 70 77
94. Lambert N.M. Hartsough C.S. Prospective study of tabocco smoking and substance dependencies among samples of ADHD and non-ADHD participants J Learn Disabil 31 1998 533 544
95. Law S.E. Schachar R.J. Do typical clinical diagnoses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 38 1999 944 951
96. Lerer R.J. Lerer M.P. Responses of adolescents with minimal brain dysfunction to methylphenidate J Learn Disabil 10 1977 223 228
97. Levin F.R. Evans S.M. McDowell D. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: A pilot study J Clin Psychiatry 58 1997 1 21
98. Lipkin P. Goldstein I. Adesman A. Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder Arch Pediatr Adolesc Med 148 1994 859 861
99. Loeber R. Keenan K. Interaction between conduct disorder and its comorbid conditions: Effects of age and gender Clin Psychol Rev 14 1994 497 523
100. Loney J. Kramer J. Milich R.S. The hyperactive child grows up: Predictors of symptoms, delinquency and achievement at followup Gadow K. Loney J. Psychosocial Aspects of Drug Treatment for Hyperactivity 1981 Westview Press Boulder 381 415
101. MacKay M.C. Beck L. Taylor R. Methylphenidate for adolescents with minimal brain dysfunction New York State J Med 73 1973 550 554
102. Manos M. Short E. Findling R. Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 38 1999 813 819
103. Markowitz J. Morrison S. DeVane C. Drug interactions with psychostimulants Int Clin Psychopharmacol 14 1999 1 18
104. Masand P.S. Tesar G.E. Use of stimulants in the medically ill Psychiatr Clin North Am 19 1996 515 547
105. Mattes J.A. Boswell L. Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults Arch Gen Psychiatry 41 1984 1059 1063
106. Mayes S. Crites D. Bixler E. Methylphenidate and ADHD: Influence of age, IQ, and neurodevelopmental status Dev Med Child Neurol 36 1994 1099 1107
107. McBride M.C. Wang D.D. Torres C.F. Methylphenidate in therapeutic doses does not lower seizure threshold (abstract) Arm Neurol 20 1986 428
108. Musten L.M. Firestone P. Pisterman S. Effects of methylphenidate on preschool children with ADHD: Cognitive and behavioral functions J Am Acad Child Adolesc Psychiatry 36 1997 1407 1415
109. Page J.G. Bernstein J.E. Janicki R.S. A multi-clinic trial of pemoline in childhood hyperkineses Connors C.K. Clinical Uses of Stimulant Drugs in Children 1974 Excepta Medical Amsterdam 98 124
110. Patrick K. Straughn A. Jarvi E. The absorption of sustained-release methylphenidate formulations compared to an immediate-release formulation Biopharm Drug Dispos 10 1989 165 171
111. Patrick K.S. Caldwell R.W. Ferris R.M. Pharmacology of the enantiomers of threomethylphenidate J Pharmocol Exp Ther 241 1987 152 158
112. Patrick K.S. Mueller R.A. Gualtieri C.T. Pharmacokinetics and Actions of Methylphenidate Meitzer H.Y. Psychopharmacology: The Third Generation of Progress 1987 Raven Press New York 1387 1396
113. Pelham W. Burrows-Maclean L. Gnagy E. OROS methylphenidate versus t.i.d. methylphenidate in regular schools settings Scientific Proceedings of the American Academy of Child and Adolescent Psychiatry 1999 American Academy of Child and Adolescent Psychiatry Chicago
114. Pelham W.E. Aronoff H.R. Midlam J.K. A comparison of Ritalin and Adderal: Efficacy and time-course in children with Attention-deficit/Hyperactivity Disorder Pediatrics 103 1999 1 14
115. Pliszka S.R. Tricyclic antidepressants in the treatment of children with attention deficit disorder J Am Acad Child Adolesc Psychiatry 26 1987 127 132
116. Pliszka S.R. Effect of anxiety on cognition, behavior, and stimulant response in ADHD J Am Acad Child Adolesc Psychiatry 28 1989 882 887
117. Quinn D. Methylphenidate: The role of the d-Isomer Greenhill L. Osman B. Ritalin: Theory and Practice 1999 Mary Ann Liebert New York 369 374
118. Rapoport J.L. Buschsbaum M.S. Zahn T.P. Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys Science 199 1978 560 562
119. Rapport M.D. DuPaul G.J. Hyperactivity and methylphenidate: Rate-dependent effects on attention Int Clin Psychopharmacol 1 1986 45 52
120. Rapport M.D. DuPaul G.J. Kelly K.L. Attention deficit hyperactivity disorder and methylphenidate: The relationship between gross body weight and drug response in children Psychopharmacol Bull 25 1989 285 290
121. Rapport M.D. Jones J.T. DuPaul G.J. Attention deficit disorder and methylphenidate: Group and single-subject analyses of dose effects on attention in clinic and classroom settings J Clin Child Psychol 16 1987 329 338
122. Rapport M.D. Quinn S.O. DuPaul G.J. Attention deficit disorder with hyperactivity and methylphenidate: The effects of dose and mastery level on children’s learning performance J Abnorm Child Psychol 17 1989 669 689
123. Rapport M.D. Stoner G. DuPaul G.J. Attention deficit disorder and methylphenidate: A multilevel analysis of dose-response effects on children’s impulsivity across settings J Am Acad Child Adolesc Psychiatry 27 1988 60 69
124. Ratey J. Greenberg M. Lindem K. Combination of treatments for attention deficit disorders in adults J Nerv Ment Dis 176 1991 699 701
125. Riggs P.D. Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder J Am Acad Child Adolesc Psychiatry 37 1998 331 332
126. Safer D. Allen R. Barr E. Depression of growth in hyperactive children on stimulant drugs New Engl J Med 287 1972 217 220
127. Safer D. Zito J. Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of ADHD Greenhill L. Osman B. Ritalin: Theory and Practice 1999 Mary Ann Liebert New York 7 26
128. Safer D.J. Allen R.P. Stimulant drug treatment of hyperactive adolescents Dis Nerv Syst 36 1975 454 457
129. Safer D.J. Zito J.M. Fine E.M. Increased methylphenidate usage for attention deficit disorder in the 1990s Pediatrics 98 1996 1084 1088
130. Sallee F. Stiller R. Perel J. Oral pemoline kinetics in hyperactive children Clin Pharmacol Ther 37 1985 606 609
131. Satterfield J.H. Cantwell D.P. Schell A. Growth of hyperactive children treated with methylphenidate Arch Gen Psychiatry 36 1979 212 217
132. Satterfield J.H. Hoppe C.M. Schell A.M. A prospective study of delinquency in 110 adolescent boys with attention deficit disorder and 88 normal adolescent boys Am J of Psychiatry 139 1982 795 798
133. Schachar R. Tannock R. Childhood hyperactivity and psychostimulants: A review of extended treatment studies J Child Adolesc Psychopharmacol 3 1993 81 97
134. Schachar R. Tannock R. Cunningham C. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate J Am Acad Child Adolesc Psychiatry 36 1997 754 763
135. Schleifer N. Weiss G. Cohen N. Hyperactivity in preschoolers and the effect of methylphenidate Am J Orthopsychiatry 45 1975 38 50
136. Sebrechts M.M. Shaywitz S.E. Shaywitz B.A. Components of attention, methylphenidate dosage, and blood levels and children with attention deficit disorder Pediatrics 77 1986 222 228
137. Semrud-Clikeman M. Biederman J. Sprich-Buckminster S. Comorbidity between ADDH and learning disability: A review and report in a clinically referred sample J Am Acad Child Adolesc Psychiatry 31 1992 439 448
138. Shaywitz B. Fletcher J. Holahan J. Interrelationships between reading disability and attention deficit hyperactivity disorder Child Neuropsychol 1 1995 170 186
139. Shaywitz B.A. Klopper J.H. Gordon J.W. Methylphenidate in 6-hydroxydopamine treated developing rat pups: Effects on activity and maze performance Arch Neurol 35 1978 463 469
140. Shekim W.O. Asarnow R.F. Hess E. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state Comprehensive Psychiatry 31 1990 416 425
141. Shekim W.O. Asarnow R.F. Hess E. A clinical and demographic profile of a sample of adults with Attention Deficit Hyperactivity Disorder, residual state Comprehensive Psychiatry 31 1990 416 425
142. Shevell M. Schreiber R. Pemoline-associated hepatic failure: A critical analysis of the literature Pediatr Neurol 16 1996 14 16
143. Smith B. Pelham W. Gnagy E. Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence J Am Acad Child Adolesc Psychiatry 37 1998 314 321
144. Solanto M.V. Wender E.H. Does methylphenidate constrict cognitive functioning? J Am Acad Child Adolesc Psychiatry 28 1989 897 902
145. Spencer T. Biederman J. Wilens T. Adults with Attention-Deficit/Hyperactivity Disorder: A controversial diagnosis J Clin Psychiatry 59 1998 59 68 (suppl)
146. Spencer T. Biederman J. Wilens T. Pharmacotherapy of attention deficit disorder across the life cycle J Am Acad Child Adolesc Psychiatry 35 1996 409 432
147. Spencer T. Wilens T. Biederman J. Effectiveness and tolerability of Adderall for ADHD in adults Scientific Proceedings of the American Academy of Child and Adolescent Psychiatry 1999 American Academy of Child and Adolescent Psychiatry Chicago
148. Spencer T. Wilens T.E. Biederman J. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder Arch Gen Psychiatry 52 1995 434 443
149. Spencer T.J. Biederman J. Harding M. Growth deficits in ADHD children revisited: Evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiatry 35 1996 1460 1469
150. Sverd J. Gadow K.D. Nolan E.E. Methylphenidate in hyperactive boys with comorbid tic disorder. I. Clinic evaluations Adv Neurol 58 1992 271 281
151. Swanson J. Gupta S. Guinta D. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children Clin Pharmacol Ther 66 1999 295 305
152. Swanson J. Lerner M. Williams L. More frequent diagnosis of attention deficit- hyperactivity disorder N Engl J Med 333 1995 944
153. Swanson J. McBurnett K. Christian D. Stimulant medications and the treatment of children with ADHD Adv Clin Child Psychol 17 1995 265 322
154. Swanson J. Wigal S. Greenhill L. Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting Psychopharmacol Bull 34 1998 55 60
155. Swanson J. Wigal S. Greenhill L. Analog classroom assessment of Adderall in children with ADHD J Am Acad Child Adolesc Psychiatry 37 1998 519 525
156. Swanson J.M. Granger D. Kliewer W. Natural social behaviors in hyperactive children: Dose effects of methylphenidate J Consult Clin Psychol 55 1987 187 193
157. Tannock R. Ickowicz A. Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety J Am Acad Child Adolesc Psychiatry 34 1995 886 896
158. Taylor E. Schachar R. Thorley G. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behavior Psychol Med 17 1987 121 143
159. Thiele E.A. Gonzalez-Heydrich J. Riviello J.J. Epilepsy in children and adolescents Child Adolesc Psychiatr Clin North Am 8 1999 671 694
160. Varley C.K. Effects of methylphenidate in adolescents with attention deficit disorder J of the American Academy of Child Psychiatry 22 1983 351 354
161. Voelker S.L. Lachar D. Gdowski C.L. The personality inventory for children and response to methylphenidate: Preliminary evidence for predictive validity J Pediatr Psychol 8 1983 161 169
162. Volkow N. Wang G. Fowler J. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate Am J Psychiatry 155 1998 1325 1331
163. Volkow N.D. Ding Y. Fowler J.S. Is methylphenidate like cocaine? Arch Gen Psychiatry 52 1995 456 463
164. Wender P.H. Reimherr F.W. Wood D. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults Am J Psychiatry 142 1985 547 552
165. Wender P.H. Reimherr F.W. Wood D.R. Attention deficit disorder (‘minimal brain dysfunction’) in adults: A replication study of diagnosis and drug treatment Arch Gen Psychiatry 38 1981 449 456
166. Wender P.H. Wood D.R. Reimherr F.W. Pharmacological treatment of attention deficit disorder residual type (ADD, RT, “minimal brain dysfunction”, “hyperactivity”) in adults Psychopharmacol Bull 21 1985 222 230
167. Werry J. Aman M. Methylphenidate and haloperidol in children. Effects on memory and activity Arch Gen Psychiatry 32 1975 790 795
168. West S. McElroy S. Strakowski S. Attention deficit hyperactivity disorder in adolescent mania Am J Psychiatry 152 1995 271 273
169. Whalen C. Henker B. Swanson J. Natural social behaviors in hyperactive children: Dose effects of methylphenidate J Consult Clin Psychol 55 1987 187 193
170. Whalen C.K. Henker B. Dotemoto S. Hyperactivity and methylphenidate: Peer interaction styles Gadow K.D. Loney J. Psychosocial Aspects of Drug Treatment for Hyperactivity 1981 Westview Press Boulder, CO 295 324
171. Whalen C.K. Henker B. Granger D.A. Social judgement processes in hyperactive boys: Effects of methylphenidate and comparisons with normal peers J Abnorm Child Psychol 18 1990 297 316
172. Wilens T. AOD Use and Attention Deficit/Hyperactivity Disorder Alcohol Health Res World 22 1999 127 130
173. Wilens T. Long-term ADHD treatment with OROS methylphenidate 2000 Scientific Proceedings of the American Psychiatric Association Chicago May
174. Wilens T. Spencer T. Pharmacology of amphetamines Tarter R. Ammerman R. Ott P. Handbook of Substance Abuse: Neurobehavioral Pharmacology 1998 Plenum Press New York 501 513
175. Wilens T.E. Biederman J. The stimulants Psychiatr Clin North Am 15 1992 191 222
176. Wilens T.E. Biederman J. Spencer T.J. Controlled trial of high doses of Pemoline for adults with attention-deficit/hyperactivity disorder J Clin Psychopharmacol 19 1999 257 264
177. Wood D.R. Reimherr F.W. Wender P.H. Diagnosis and treatment of minimal brain dysfunction in adults Arch Gen Psychiatry 33 1976 1453 1460
178. Wozniak J. Biederman J. Kiely K. Mania-like symptoms suggestive of childhood- onset bipolar disorder in clinically referred children J Am Acad Child Adolesc Psychiatry 34 1995 867 876
179. Zametkin A. Liotta W. The neurobiology of attention-deficit/hyperactivity disorder J Clin Psychiatry 59 1998 17 23